MEET THE
TEAM
Mining engineers. Radiologists. Capital markets veterans. Regulatory experts. Voyageur’s strength is in the range of expertise pointed at a single outcome: a secure, domestic contrast media supply chain from resource to finished product.
Voyageur Leadership
Voyageur’s leadership combines the mining engineering expertise that discovered and advanced the Frances Creek barite deposit with corporate finance leadership from Lafarge and medical-device commercialisation experience: a team with a track record of moving resource discoveries from exploration through to cash-flowing production.
Brent Willis
Brad Willis
Albert Deslauriers
Ethan Mohan
Board of Directors
Voyageur’s Board pairs deep capital markets experience with decades of pharmaceutical and life sciences leadership. Directors include veterans of US IPOs, Fortune 100 risk management, and multi-billion-dollar corporate banking bringing the financial rigor and industry insight needed to guide Voyageur through its next phase of growth.
Eugene (Gene) Fritzel
Eric S Pommer
Kevin McBeth
Beth Shaw
Christopher Van Buren
Jeffrey Kraws
Virginia Alling
VOYAGEUR EXECUTIVE TEAM
Voyageur’s Executive Team brings leading radiology and imaging expertise from institutions including Mayo Clinic and Evangelical Hospital Düsseldorf. Established in 2021, the board guides clinical validation of Voyageur’s barium and iodine contrast media, ensuring every product meets rigorous imaging and safety standards.
Dr. Iryna Saranchova
Dr. Ibrahim Hashmi
Brian Mueller
Kyle Peterson
SCIENTIFIC ADVISORY BOARD
Voyageur’s Scientific Advisory Board of M.D. advisors provides the clinical and regulatory expertise behind five Health Canada–licensed barium contrast products, already generating commercial revenue. Their guidance underpins Voyageur’s push toward US FDA approval and North America’s largest contrast media market.